Calcium metabolism

About 100 million people worldwide suffer from degenerative joint disease and presumably its incidence will further increase due to demographic and lifestyle changes.

The loss of articular cartilage during joint destruction is irreversible and current therapies are unsuitable to stop or even reverse cartilage loss.

Thus, it is of special importance to diagnose degenerative joint diseases as early as possible and to start an appropriate therapy before the disease has become radiologically apparent.
With the measurement of biomarkers, degenerative joint diseases can be a) detected already in the initial stage, b) monitored or c) even predicted.

Cat-Nr.Product name
804625-OH-Vitamin D direct (Quidel®)
60-4000Anti-human PTH 1-34 Antibody
60-6100FGF-23 (C-Term) 2nd Generation
60-6300FGF-23 (C-Term) Mouse
CY-4000FGF-23 Intact, Human (Kainos)
60-6600FGF-23 Intact, Human 2nd Generation
KT-800Human Fetuin-A
27998Klotho, Human
60-3900PTH 1-34 Human, high sensitive
60-3000PTH 1-84 Bioactive, Human
60-2700PTH 1-84 Bioactive, Rat
8044PTH 1-84 Intact, Human
60-2305PTH 1-84 Intact, Mouse
60-2500PTH 1-84 Intact, Rat
60-3200PTH C-Terminal, Human
60-2200PTH C-Terminal, Rat
60-3100PTH, 1-84, Horse, Bovine, Dog, Human

Back to overview